Boston-based biotech firm Conagen says it has come up with a novel and proprietary process for the scalable production of a non-GMO version of 2’-fucosyllactose (2’FL), a human milk oligosaccharide (HMO) found in human breastmilk that is becoming a sought-after...
Roquette will develop protein ingredients using the high-protein pea variety developed by seed breeding company Equinom, and jointly invest $4 million (€3.5m) in the firm to develop new products.